Bhasker Aparna Govil, Khaitan Manish, Bindal Vivek, Kumar Amardeep, Rajkumar Anirudh, Kaushal Anshuman, Prasad Arun, Parikh Chirag, Sethi Daksh, Goel Deep, Hareendran Deepak Thampi, Bedi Digvijay, Jammu Gurvinder Singh, Leo Jayanth, Kular Kuldeepak, Narwaria Mahendra, Chikkachanappa Mahesh, Motwani Manish, Bharucha Manoj, Ismail Mohamed, Dukkipati Nandkishore, Shah Neha, Tantia Om, Patel Parag, Padmakumar R, Singh Rahul, Palaniappan Raj, Shrivastava Rajesh, Pal Rajput Ram Raksha, Goel Ramen, Wadhawan Randeep, Garg Rohit, Aggarwal Sandeep, Patolia Sanjay, Baig Sarfaraz J, Shah Shashank, Shivaram H V, Dhorepatil Shrihari, Saggu Sukhvinder Singh, Ugale Surendra, Perungo T, Soni Vandana
Saifee Hospital, Mumbai, Maharashtra, India.
K D Hospital, Ahmedabad, Gujarat, India.
J Minim Access Surg. 2021 Oct-Dec;17(4):542-547. doi: 10.4103/jmas.JMAS_2_21.
Although safe practice guidelines were issued by the Obesity and Metabolic Surgery Society of India (OSSI) in the end of May 2020, surgeons have been in a dilemma about risk of subjecting patients to hospitalisation and bariatric surgery. This survey was conducted with the objective to evaluate the risk of coronavirus disease-19 (COVID-19) infection in peri- and post-operative period after bariatric and metabolic surgery (BMS).
A survey with OSSI members was conducted from 20 July 2020 to 31 August 2020 in accordance with EQUATOR guidelines. Google Form was circulated to all surgeon members through E-mail and WhatsApp. In the second phase, clinical details were captured from surgeons who reported positive cases.
One thousand three hundred and seven BMS were reported from 1 January 2020 to 15 July 2020. Seventy-eight per cent were performed prior to 31 March 2020 and 276 were performed after 1 April 2020. Of these, 13 (0.99%) patients were reported positive for COVID-19 in the post-operative period. All suffered from a mild disease and there was no mortality. Eighty-seven positive cases were reported from patients who underwent BMS prior to 31 December 2019. Of these, 82.7% of patients had mild disease, 13.7% of patients had moderate symptoms and four patients succumbed to COVID-19.
BMS may be considered as a safe treatment option for patients suffering from clinically severe obesity during the COVID-19 pandemic. Due care must be taken to protect patients and healthcare workers and all procedures must be conducted in line with the safe practice guidelines.
尽管印度肥胖与代谢外科学会（OSSI）于2020年5月底发布了安全实践指南，但外科医生对于让患者住院及进行减肥手术的风险仍感到两难。开展这项调查的目的是评估减肥与代谢手术（BMS）围手术期及术后感染冠状病毒病（COVID-19）的风险。
根据EQUATOR指南，于2020年7月20日至8月31日对OSSI成员进行了一项调查。通过电子邮件和WhatsApp向所有外科医生成员发放了谷歌表单。在第二阶段，从报告了阳性病例的外科医生那里获取了临床细节。
2020年1月1日至7月15日共报告了1307例BMS。其中78%在2020年3月31日前进行，276例在2020年4月1日后进行。在这些病例中，有13例（0.99%）患者在术后被报告为COVID-19阳性。所有患者病情均较轻，无死亡病例。2019年12月31日前接受BMS的患者中有87例报告为阳性。其中，82.7%的患者病情较轻，13.7%的患者有中度症状，4例患者死于COVID-19。
在COVID-19大流行期间，对于临床严重肥胖患者，BMS可被视为一种安全的治疗选择。必须谨慎保护患者和医护人员，所有手术都必须按照安全实践指南进行。
